Tullio Florio Selected Research

CXCR4 Receptors (CXCR4 Receptor)

1/2014	CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.
1/2010	Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.
8/2008	Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas.
1/2007	CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
4/2003	Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt.
11/2002	Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tullio Florio Research Topics

Disease

77	Neoplasms (Cancer) 02/2022 - 04/2003
25	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 04/2003
14	Pituitary Neoplasms (Pituitary Adenoma) 01/2020 - 10/2002
13	Neuroblastoma 06/2021 - 02/2002
13	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2019 - 02/2002
12	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 12/2006
11	Glioma (Gliomas) 02/2022 - 07/2004
8	Neuroendocrine Tumors (Neuroendocrine Tumor) 08/2019 - 01/2008
6	Brain Neoplasms (Brain Tumor) 01/2020 - 11/2002
6	Adenoma (Adenomas) 01/2020 - 10/2002
6	Carcinogenesis 01/2020 - 01/2010
5	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2019 - 01/2012
4	Scrapie 11/2019 - 12/2007
4	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2008
4	Malignant Mesothelioma 01/2017 - 08/2011
4	Meningioma (Meningiomas) 05/2011 - 01/2004
3	Neoplasm Metastasis (Metastasis) 12/2020 - 08/2005
3	Mesothelioma 01/2017 - 03/2010
3	Inflammation (Inflammations) 01/2017 - 11/2002
3	Tics (Tic) 01/2017 - 03/2009
3	Growth Hormone-Secreting Pituitary Adenoma 01/2016 - 07/2003
3	Gliosis 11/2007 - 04/2003
2	Osteosarcoma (Osteogenic Sarcoma) 01/2018 - 05/2016
2	Primitive Neuroectodermal Tumors (PNET) 06/2017 - 10/2014
2	Brain Diseases (Brain Disorder) 01/2016 - 01/2007
2	Carcinoma (Carcinomatosis) 04/2015 - 04/2012
2	Infections 01/2014 - 11/2002
2	Amyloid Plaque 01/2012 - 01/2007
2	Ovarian Neoplasms (Ovarian Cancer) 01/2010 - 08/2005

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2004
17	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2018 - 07/2003
15	Pharmaceutical PreparationsIBA 06/2021 - 01/2010
14	Prion ProteinsIBA 11/2019 - 02/2002
13	LigandsIBA 04/2021 - 11/2002
13	Peptides (Polypeptides)IBA 01/2020 - 04/2003
12	Amyloid (Amyloid Fibrils)IBA 01/2020 - 12/2006
11	Metformin (Glucophage)FDA LinkGeneric 02/2022 - 01/2013
11	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2021 - 05/2003
11	ChemokinesIBA 01/2014 - 04/2003
10	Protein Isoforms (Isoforms)IBA 06/2021 - 10/2002
9	Chemokine ReceptorsIBA 12/2020 - 11/2002
9	Biological ProductsIBA 08/2019 - 01/2010
9	Messenger RNA (mRNA)IBA 02/2017 - 04/2003
7	Octreotide (Sandostatin)FDA LinkGeneric 04/2021 - 02/2006
7	Chemokine CXCL12IBA 08/2008 - 11/2002
6	Cisplatin (Platino)FDA LinkGeneric 06/2021 - 01/2015
6	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2014 - 11/2002
5	Growth Hormone (Somatotropin)IBA 04/2021 - 10/2002
5	Phosphotransferases (Kinase)IBA 02/2013 - 04/2003
5	DNA (Deoxyribonucleic Acid)IBA 08/2008 - 07/2003
4	Hormones (Hormone)IBA 01/2020 - 07/2003
4	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 02/2002
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 04/2015
4	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 02/2013
4	Protein Tyrosine PhosphatasesIBA 02/2017 - 07/2004
4	Amyloid beta-PeptidesIBA 05/2007 - 12/2006
4	ThymidineIBA 01/2007 - 07/2003
3	Immune Checkpoint InhibitorsIBA 02/2022 - 12/2020
3	rat CLIC1 proteinIBA 02/2022 - 10/2015
3	ChloridesIBA 02/2022 - 11/2014
3	BiguanidesIBA 02/2022 - 01/2018
3	pasireotideIBA 04/2021 - 10/2014
3	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 01/2013
3	RNA (Ribonucleic Acid)IBA 01/2017 - 10/2010
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017 - 12/2006
3	NestinIBA 01/2017 - 03/2009
3	Untranslated RNA (Noncoding RNA)IBA 12/2015 - 02/2011
3	Gefitinib (Iressa)FDA Link 03/2010 - 01/2008
3	ErbB Receptors (EGF Receptor)IBA 03/2009 - 08/2005
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2007 - 10/2002
2	FendilineIBA 06/2021 - 11/2020
2	Acetazolamide (Diamox)FDA LinkGeneric 06/2021 - 11/2020
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2002
2	tau Proteins (tau Protein)IBA 01/2020 - 01/2012
2	Growth Factor ReceptorsIBA 11/2019 - 01/2013
2	Histone Deacetylase InhibitorsIBA 05/2019 - 01/2016
2	Chloride Channels (Chloride Channel)IBA 01/2019 - 10/2015
2	Ion Channels (Ion Channel)IBA 01/2019 - 10/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 11/2018 - 10/2015
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 11/2011
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2018 - 01/2007
2	Epidermal Growth Factor (EGF)IBA 01/2017 - 03/2010
2	Interleukin-8 (Interleukin 8)IBA 01/2017 - 12/2006
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 06/2008
2	LipopolysaccharidesIBA 11/2016 - 04/2003
2	PrionsIBA 01/2016 - 01/2007
2	Differentiation AntigensIBA 12/2015 - 07/2012
2	Temozolomide (Temodar)FDA LinkGeneric 01/2015 - 01/2015
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 03/2012 - 06/2011
2	Cabergoline FDA LinkGeneric 06/2011 - 06/2008
2	somatostatin receptor type 1IBA 11/2009 - 07/2003
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2009 - 07/2003
2	phosphotyrosine phosphatase etaIBA 09/2008 - 12/2004
2	PresenilinsIBA 05/2007 - 01/2007
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2007 - 12/2006

Therapy/Procedure

32	Therapeutics 06/2021 - 01/2004
8	Drug Therapy (Chemotherapy) 06/2021 - 01/2010
4	Radiotherapy 03/2016 - 05/2012
2	Precision Medicine 02/2022 - 12/2020
2	Combined Modality Therapy 01/2015 - 01/2014